Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · IEX Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Jul 2, 2024, 4:00 PM
1.340
+0.030 (2.29%)
After-hours: Jul 2, 2024, 7:08 PM EDT
Unity Biotechnology Market Cap
Unity Biotechnology has a market cap or net worth of $21.99 million as of July 2, 2024. Its market cap has decreased by -50.80% in one year.
Market Cap
21.99M
Enterprise Value
8.27M
1-Year Change
-50.80%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since May 3, 2018, Unity Biotechnology's market cap has decreased from $697.70M to $21.99M, a decrease of -96.85%. That is a compound annual growth rate of -42.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 22.00M | -21.99% |
| Dec 29, 2023 | 28.20M | -27.51% |
| Dec 30, 2022 | 38.90M | -53.86% |
| Dec 31, 2021 | 84.30M | -69.60% |
| Dec 31, 2020 | 277.30M | -16.27% |
| Dec 31, 2019 | 331.20M | -51.87% |
| Dec 31, 2018 | 688.20M | -1.36% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OneMedNet | 22.27M |
| Biora Therapeutics | 22.25M |
| Vincerx Pharma | 22.21M |
| Minerva Neurosciences | 22.10M |
| Akari Therapeutics, | 22.05M |
| Aprea Therapeutics | 21.83M |
| Apollomics | 21.77M |
| NanoViricides | 21.38M |